GLAUKOS Corp GKOS
5 trading plans running, 35 Form 144 notices for $91.7M
10-Q, 10-K and Form 144What GKOS's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.
Plans adopted or ended
Trading plans · XBRL, 10-Q and 10-K
From Jun 11, 2025 to Jun 30, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.
| Insider | What | Date | Reported in | ||
|---|---|---|---|---|---|
| Thomas Burn Chairman and Chief Executive Officer |
Adopted 10b5-1 plan | Aug 20, 2026 | 10-Q Oct 28, 2026 | ||
What the company wroteOn August 20, 2026 , Thomas Burn s, the Company’s Chairman and Chief Executive Officer , adopted a 10b5-1 trading plan (the Burns Trading Plan). The Burns Trading Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Burns Trading Plan provides for the potential sale of 280,000 shares of the Company’s common stock commencing November 18, 2026. The Burns Trading Plan terminates on the earlier of June 30, 2027 or the date all shares under the plan are sold. | |||||
| Alex Thurman Senior Vice President and Chief Financial Officer |
Adopted 10b5-1 plan | Aug 18, 2026 | 10-Q Oct 28, 2026 | ||
What the company wroteOn August 18, 2026 , Alex Thurman , the Company’s Senior Vice President and Chief Financial Officer , adopted a 10b5-1 trading plan (the Thurman Trading Plan). The Thurman Trading Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Thurman Trading Plan provides for the potential sale of 17,752 shares of the Company’s common stock commencing November 18, 2026. The Thurman Trading Plan terminates on the earlier of March 25, 2027 or the date all shares under the plan are sold. | |||||
| Joe Gilliam President and Chief Operating Officer |
Adopted 10b5-1 plan | Aug 13, 2026 | 10-Q Oct 28, 2026 | ||
What the company wroteInsider Trading Arrangements On August 13, 2026 , Joe Gilliam , the Company’s President and Chief Operating Officer , adopted a 10b5-1 trading plan (the Gilliam Trading Plan). The Gilliam Trading Plan is intended to satisfy the affirmative defense of R ule 10b5-1(c) under the Exchange Act. The Gilliam Trading Plan provides for the potential sale of 59,890 shares of the Company’s common stock commencing November 12, 2026. The Gilliam Trading Plan terminates on the earlier of April 30, 2027 or the date all shares under the plan are sold. | |||||
| Tomas Navratil Chief Development Officer |
Adopted 10b5-1 plan | Jun 12, 2026 | 10-Q Jul 29, 2026 | ||
What the company wroteInsider Trading Arrangements On June 12, 2026 , Tomas Navratil , the Company’s Chief Development Officer , adopted a 10b5-1 trading plan (the Navratil Trading Plan). The Navratil Trading Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Navratil Trading Plan provides for the potential sale of 15,657 shares of the Company’s common stock commencing September 16, 2026. The Navratil Trading Plan terminates on the earlier of December 31, 2026 or the date all shares under the plan are sold. | |||||
| Alex Thurman Senior Vice President and Chief Financial Officer |
Adopted 10b5-1 plan | Jun 9, 2026 | 10-Q Jul 29, 2026 | ||
What the company wroteOn June 9, 2026 , Alex Thurman , the Company’s Senior Vice President and Chief Financial Officer , adopted a 10b5-1 trading plan (the Thurman Trading Plan). The Thurman Trading Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Thurman Trading Plan provides for the potential sale of 20,000 shares of the Company’s common stock commencing September 8, 2026. The Thurman Trading Plan terminates on the earlier of December 14, 2026 or the date all shares under the plan are sold. | |||||
| Tomas Navratil Chief Development Officer |
Adopted 10b5-1 plan | Mar 12, 2026 | 10-Q Apr 30, 2026 | ||
What the company wroteInsider Trading Arrangements On March 12, 2026 , Tomas Navratil , the Company’s Chief Development Officer , adopted a 10b5-1 trading plan (the Navratil Trading Plan). The Navratil Trading Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Navratil Trading Plan provides for the potential sale of 8,125 shares of the Company’s common stock commencing June 16, 2026. The Navratil Trading Plan terminates on the earlier of September 15, 2026 or the date all shares under the plan are sold. | |||||
| Alex Thurman Senior Vice President and Chief Financial Officer |
Adopted 10b5-1 plan | Dec 15, 2025 | 10-K Feb 23, 2026 | ||
What the company wroteAdditionally, on December 15, 2025 , Alex Thurman , the Company’s Senior Vice President and Chief Financial Officer , adopted a 10b5-1 trading plan (the Thurman Trading Plan). The Thurman Trading Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Thurman Trading Plan provides for the potential sale of 68,521 shares of the Company’s common stock commencing March 16, 2026. The Thurman Trading Plan terminates on the earlier of August 14, 2026 or the date all shares under the plan are sold. | |||||
| Tomas Navratil Chief Development Officer |
Adopted 10b5-1 plan | Dec 15, 2025 | 10-K Feb 23, 2026 | ||
What the company wroteOn December 15, 2025 , Tomas Nav ratil , the Company’s Chief Development Officer , adopted a 10b5-1 trading plan (the Navratil Trading Plan). The Navratil Trading Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Navratil Trading Plan provides for the potential sale of 6,125 shares of the Company’s common stock commencing March 16, 2026. The Navratil Trading Plan terminates on the earlier of June 15, 2026 or the date all shares under the plan are sold. | |||||
| Alex R. Thurman Senior Vice President and Chief Financial Officer |
Adopted 10b5-1 plan | Jun 11, 2025 | 10-Q Aug 4, 2025 | ||
What the company wroteOn June 11, 2025, Alex R. Thurman, the Company’s Senior Vice President and Chief Financial Officer, adopted a new 10b5-1 trading plan (the “Thurman Trading Plan”). The Thurman Trading Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act, and provides for the potential sale of 5,000 shares of the Company’s common stock. The Thurman Trading Plan terminates on the earlier of December 12, 2025 or the date all shares are sold. | |||||
| Joseph E. Gilliam President and Chief Operating Officer |
Adopted 10b5-1 plan | Jun 11, 2025 | 10-Q Aug 4, 2025 | ||
What the company wroteOn June 11, 2025, Joseph E. Gilliam, the Company’s President and Chief Operating Officer, adopted a new 10b5-1 trading plan (the “Gilliam Trading Plan”). The Gilliam Trading Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act, and provides for the potential sale of 90,000 shares of the Company’s common stock. The Gilliam Trading Plan terminates on the earlier of June 12, 2026 or the date all shares are sold. | |||||
| Thomas W. Burns Chairman and Chief Executive Officer |
Adopted 10b5-1 plan | Jun 10, 2025 | 10-Q Aug 4, 2025 | ||
What the company wroteOn June 10, 2025, Thomas W. Burns, the Company’s Chairman and Chief Executive Officer, adopted a new 10b5-1 trading plan (the “Burns Trading Plan”). The Burns Trading Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act, and provides for the potential sale of 275,000 shares of the Company’s common stock. The Burns Trading Plan terminates on the earlier of January 23, 2026 or the date all shares are sold. | |||||
| Tomas Navratil Chief Development Officer |
Adopted 10b5-1 plan | Jun 6, 2025 | 10-Q Aug 4, 2025 | ||
What the company wroteOn June 6, 2025, Tomas Navratil, the Company’s Chief Development Officer, adopted a new 10b5-1 trading plan (the “Navratil Trading Plan”). The Trading Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Navratil Trading Plan was subsequently amended on June 12, 2025, prior to the execution of any sales thereunder. The Navratil Trading Plan, as amended, provides for the potential sale of 8,017 shares of the Company’s common stock. The Navratil Trading Plan terminates on the earlier of December 19, 2025 or the date all shares are sold. | |||||
| Marc A. Stapley Board of Directors |
Adopted 10b5-1 plan | Jun 4, 2025 | 10-Q Aug 4, 2025 | ||
What the company wroteOn June 4, 2025, Marc A. Stapley, a member of the Company’s Board of Directors, adopted a new 10b5-1 trading plan (the “Stapley Trading Plan”). The Stapley Trading Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act, and provides for the potential sale of 15,000 shares of the Company’s common stock. The Stapley Trading Plan terminates on the earlier of June 2, 2026 or the date all shares are sold. | |||||
| Alex Thurman Senior Vice President and Chief Financial Officer |
Adopted 10b5-1 plan | Dec 13, 2024 | 10-K Feb 25, 2025 | ||
What the company wroteAdditionally, on December 13, 2024, Alex Thurman, the Company’s Senior Vice President and Chief Financial Officer, adopted a 10b5-1 trading plan (the Thurman Trading Plan). The Thurman Trading Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Thurman Trading Plan provides for the potential sale of 2,752 shares of the Company’s common stock commencing March 21, 2025. The Thurman Trading Plan terminates on the earlier of June 13, 2025 or the date all shares under the plan are sold | |||||
| Marc A. Stapley member of the Company’s Board of Directors |
Ended plan | Nov 18, 2024 | 10-Q Nov 1, 2023 | ||
What the company wrote On August 11, 2023, Marc A. Stapley, a member of the Company’s Board of Directors, adopted a 10b5-1 trading plan (the “Trading Plan”). The Trading Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Trading Plan provides for the potential sale of 35,000 shares of the Company’s common stock commencing November 13, 2023. The Trading Plan terminates on the earlier of November 18, 2024 or the date all shares are sold. | |||||
| Tomas Navratil Chief Development Officer |
Adopted 10b5-1 plan | Nov 12, 2024 | 10-K Feb 25, 2025 | ||
What the company wroteOn November 12, 2024, Tomas Navratil, the Company’s Chief Development Officer, adopted a 10b5-1 trading plan (the Navratil Trading Plan). The Navratil Trading Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Navratil Trading Plan provides for the potential sale of 5,000 shares of the Company’s common stock commencing February 14, 2025. The Navratil Trading Plan terminates on the earlier of May 15, 2025 or the date all shares under the plan are sold. | |||||
| Gilbert H. Kliman, M.D. member of the Company’s Board of Directors |
Ended 10b5-1 plan | Jun 15, 2024 | 10-Q Aug 2, 2024 | ||
What the company wroteOn June 15, 2024, Gilbert H. Kliman, M.D., a member of the Company’s Board of Directors, terminated the 10b5-1 trading plan that he had entered into on March 15, 2024. On June 15, 2024, Dr. Kliman also adopted a new 10b5-1 trading plan (the “Trading Plan”). The Trading Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Trading Plan provides for the potential sale of 10,000 shares of the Company’s common stock commencing September 16, 2024. The Trading Plan terminates on the earlier of May 23, 2025 or the date all shares are sold | |||||
| Gilbert H. Kliman, M.D. member of the Company’s Board of Directors |
Adopted 10b5-1 plan | Mar 15, 2024 | 10-Q May 3, 2024 | ||
| Joseph E. Gilliam Company’s President and Chief Operating Officer |
Adopted 10b5-1 plan | Mar 4, 2024 | 10-Q May 3, 2024 | ||
| Alex R. Thurman Senior Vice President and Chief Financial Officer |
Adopted 10b5-1 plan | May 17, 2023 | 10-Q Aug 2, 2023 | ||
What the company wrote On May 17, 2023, Alex R. Thurman, the Company’s Senior Vice President and Chief Financial Officer, adopted a 10b5-1 trading plan (the “Trading Plan”). The Trading Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Trading Plan provides for the potential sale of 7,446 shares of the Company’s common stock commencing August 17, 2023. The Trading Plan terminates on the earlier of May 31, 2024 or the date all shares are sold. | |||||
Show the other 12 plans
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 4, 2023.
Notices of planned sales
Form 144 · Form 144 XML, SEC
What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).
| Filed | Seller | Shares | Value |
|---|---|---|---|
| Nov 12, 2026 | Gilliam Joseph E Officer |
44,917 | $11.1M |
| Nov 4, 2026 | Kliman Gilbert H Director |
2,500 | $632K |
| Oct 30, 2026 | Navratil Tomas Officer |
44,436 | $10.6M |
| Oct 5, 2026 | Navratil Tomas Officer |
1,527 | $251K |
| Sep 25, 2026 | Navratil Tomas Officer |
1,615 | $249K |
| Sep 16, 2026 | Navratil Tomas Officer |
1,457 | $243K |
| Aug 28, 2026 | Navratil Tomas Officer |
13,744 | $2.5M |
| Aug 19, 2026 | Kliman Gilbert H Director |
2,500 | $475K |
| Aug 11, 2026 | Gilliam Joseph E Officer |
60,000 | $10.8M |
| Aug 7, 2026 | Thurman Alex R. Officer |
20,000 | $3.6M |
| Jul 31, 2026 | WEN LEANA Director |
525 | $88K |
| Jul 16, 2026 | Thurman Alex R. Officer |
10,000 | $1.6M |
| Jul 9, 2026 | Thurman Alex R. Officer |
10,000 | $1.6M |
| Jul 6, 2026 | Thurman Alex R. Officer |
10,000 | $1.5M |
| Jul 1, 2026 | Navratil Tomas Officer |
716 | $100K |
| Jun 16, 2026 | Navratil Tomas Officer |
1,537 | $201K |
| May 14, 2026 | Kliman Gilbert H Director |
5,000 | $704K |
| May 11, 2026 | Kliman Gilbert H Director |
5,000 | $675K |
| May 1, 2026 | WEN LEANA Director |
1,700 | $247K |
| May 1, 2026 | Gilliam Joseph E Officer |
19,573 | $2.8M |
| Apr 30, 2026 | Thurman Alex R. Officer |
10,000 | $1.4M |
| Apr 10, 2026 | Navratil Tomas Officer |
2,093 | $246K |
| Mar 25, 2026 | Thurman Alex R. Officer |
2,511 | $267K |
| Mar 24, 2026 | Thurman Alex R. Officer |
1,521 | $160K |
| Mar 17, 2026 | Thurman Alex R. Officer |
625 | $62K |
| Mar 16, 2026 | Navratil Tomas Officer |
1,031 | $101K |
| Feb 19, 2026 | WEISNER AIMEE S Director |
15,000 | $1.8M |
| Jan 22, 2026 | Gilliam Joseph E Officer |
10,498 | $1.3M |
| Jan 22, 2026 | Stapley Marc Director |
15,000 | $1.9M |
| Jan 21, 2026 | Gilliam Joseph E Officer |
4,502 | $561K |
| Jan 16, 2026 | Burns Thomas William Officer, Director |
186,945 | $21.5M |
| Jan 8, 2026 | Burns Thomas William Officer, Director |
88,055 | $10.1M |
| Dec 9, 2025 | Kliman Gilbert H Director |
5,000 | $536K |
| Nov 25, 2025 | Thurman Alex R. Officer |
315 | $33K |
| Nov 18, 2025 | Gilliam Joseph E Officer |
19,340 | $1.7M |
Show the other 27 notices
From the Form 144 XML filed with the SEC, since Nov 18, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.
Sources
Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.
Also
Insider trades: the Form 4s for the sales these plans led to.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/GKOS/export.csv") into a cell.